How social media intelligence can signal blockbuster success: BMS’ Opdivo

This episode explores how social media intelligence revealed early signals of blockbuster success for Bristol Myers Squibb’s cancer immunotherapy, Opdivo. By analysing healthcare professional conversations online, CREATION.co uncovered insights that shaped understanding of product launches in pharma and the wider implications for future treatments.

In The Social Intelligence Podcast, two AI hosts break down fresh research from CREATION.co’s analysts. This episode is based on an article by Jessica Fernandes, Analyst at CREATION.co.

Read the full article and discover more insights at https://creation.co